<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-03-18" modified="2020-08-12" version="159">
<accession>Q9NRF2</accession>
<accession>A8K2R7</accession>
<accession>Q96FK3</accession>
<accession>Q96SX3</accession>
<accession>Q9NRF1</accession>
<accession>Q9NRF3</accession>
<accession>Q9P2P7</accession>
<accession>Q9Y3Y3</accession>
<name>SH2B1_HUMAN</name>
<protein>
<recommendedName>
<fullName>SH2B adapter protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Pro-rich, PH and SH2 domain-containing signaling mediator</fullName>
<shortName>PSM</shortName>
</alternativeName>
<alternativeName>
<fullName>SH2 domain-containing protein 1B</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SH2B1</name>
<name type="synonym">KIAA1299</name>
<name type="synonym">SH2B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="2607" last="2621">
<title>Kinase activation through dimerization by human SH2-B.</title>
<authorList>
<person name="Nishi M."/>
<person name="Werner E.D."/>
<person name="Oh B.C."/>
<person name="Frantz J.D."/>
<person name="Dhe-Paganon S."/>
<person name="Hansen L."/>
<person name="Lee J."/>
<person name="Shoelson S.E."/>
</authorList>
<dbReference type="PubMed" id="15767667"/>
<dbReference type="DOI" id="10.1128/mcb.25.7.2607-2621.2005"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>FUNCTION IN JAK2 ACTIVATION</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>INTERACTION WITH JAK2; SH2B2; INSR AND IGF1R</scope>
<scope>PHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF PHE-29; ALA-34; ALA-38; PHE-41; ALA-42; TYR-48; PHE-68; PHE-72 AND ARG-555</scope>
<scope>VARIANT ALA-484</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="DNA Res." volume="7" first="65" last="73">
<title>Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Kikuno R."/>
<person name="Ishikawa K."/>
<person name="Hirosawa M."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10718198"/>
<dbReference type="DOI" id="10.1093/dnares/7.1.65"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT ALA-541</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Teratocarcinoma</tissue>
<tissue>Tongue</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 144-756 (ISOFORM 3)</scope>
<scope>VARIANT ALA-484</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 60-756 (ISOFORM 2)</scope>
<source>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="J. Biochem." volume="122" first="1105" last="1113">
<title>PSM, an insulin-dependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor.</title>
<authorList>
<person name="Riedel H."/>
<person name="Wang J."/>
<person name="Hansen H."/>
<person name="Yousaf N."/>
</authorList>
<dbReference type="PubMed" id="9498552"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a021868"/>
</citation>
<scope>INTERACTION WITH INSR</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Biochem. J." volume="335" first="103" last="109">
<title>SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase.</title>
<authorList>
<person name="Kotani K."/>
<person name="Wilden P."/>
<person name="Pillay T.S."/>
</authorList>
<dbReference type="PubMed" id="9742218"/>
<dbReference type="DOI" id="10.1042/bj3350103"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH INSR</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="21239" last="21245">
<title>Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta.</title>
<authorList>
<person name="Rui L."/>
<person name="Carter-Su C."/>
</authorList>
<dbReference type="PubMed" id="9694882"/>
<dbReference type="DOI" id="10.1074/jbc.273.33.21239"/>
</citation>
<scope>FUNCTION IN PDGF SIGNALING</scope>
<scope>INTERACTION WITH PDGFRA/B</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Mamm. Genome" volume="10" first="1160" last="1167">
<title>Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.</title>
<authorList>
<person name="Nelms K."/>
<person name="O'Neill T.J."/>
<person name="Li S."/>
<person name="Hubbard S.R."/>
<person name="Gustafson T.A."/>
<person name="Paul W.E."/>
</authorList>
<dbReference type="PubMed" id="10594240"/>
<dbReference type="DOI" id="10.1007/s003359901183"/>
</citation>
<scope>INTERACTION WITH INSR AND ISR1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="8673" last="8681">
<title>SH2-B family members differentially regulate JAK family tyrosine kinases.</title>
<authorList>
<person name="O'Brien K.B."/>
<person name="O'Shea J.J."/>
<person name="Carter-Su C."/>
</authorList>
<dbReference type="PubMed" id="11751854"/>
<dbReference type="DOI" id="10.1074/jbc.m109165200"/>
</citation>
<scope>INTERACTION WITH JAK1; JAK2 AND JAK3</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="15962" last="15970">
<title>Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation.</title>
<authorList>
<person name="Kong M."/>
<person name="Wang C.S."/>
<person name="Donoghue D.J."/>
</authorList>
<dbReference type="PubMed" id="11827956"/>
<dbReference type="DOI" id="10.1074/jbc.m102777200"/>
</citation>
<scope>FUNCTION IN FGF SIGNALING</scope>
<scope>INTERACTION WITH FGFR3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="133" last="141">
<title>SH2-B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells.</title>
<authorList>
<person name="Wang X."/>
<person name="Chen L."/>
<person name="Maures T.J."/>
<person name="Herrington J."/>
<person name="Carter-Su C."/>
</authorList>
<dbReference type="PubMed" id="14565960"/>
<dbReference type="DOI" id="10.1074/jbc.m310040200"/>
</citation>
<scope>FUNCTION IN NGF SIGNALING</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="J. Cell Sci." volume="119" first="1666" last="1676">
<title>Interaction of SH2-Bbeta with RET is involved in signaling of GDNF-induced neurite outgrowth.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Zhu W."/>
<person name="Wang Y.G."/>
<person name="Liu X.J."/>
<person name="Jiao L."/>
<person name="Liu X."/>
<person name="Zhang Z.H."/>
<person name="Lu C.L."/>
<person name="He C."/>
</authorList>
<dbReference type="PubMed" id="16569669"/>
<dbReference type="DOI" id="10.1242/jcs.02845"/>
</citation>
<scope>FUNCTION IN GDNF SIGNALING</scope>
<scope>INTERACTION WITH RET</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="6546" last="6559">
<title>SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.</title>
<authorList>
<person name="Donatello S."/>
<person name="Fiorino A."/>
<person name="Degl'Innocenti D."/>
<person name="Alberti L."/>
<person name="Miranda C."/>
<person name="Gorla L."/>
<person name="Bongarzone I."/>
<person name="Rizzetti M.G."/>
<person name="Pierotti M.A."/>
<person name="Borrello M.G."/>
</authorList>
<dbReference type="PubMed" id="17471236"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210480"/>
</citation>
<scope>FUNCTION IN RET SIGNALING</scope>
<scope>INTERACTION WITH PRKAR1A/RET</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-270</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<comment type="function">
<text evidence="5 11 12 13 14 15 17 18">Adapter protein for several members of the tyrosine kinase receptor family. Involved in multiple signaling pathways mediated by Janus kinase (JAK) and receptor tyrosine kinases, including the receptors of insulin (INS), insulin-like growth factor I (IGF1), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), platelet-derived growth factor (PDGF) and fibroblast growth factors (FGFs). In growth hormone (GH) signaling, autophosphorylated ('Tyr-813') JAK2 recruits SH2B1, which in turn is phosphorylated by JAK2 on tyrosine residues. These phosphotyrosines form potential binding sites for other signaling proteins. GH also promotes serine/threonine phosphorylation of SH2B1 and these phosphorylated residues may serve to recruit other proteins to the GHR-JAK2-SH2B1 complexes, such as RAC1. In leptin (LEP) signaling, binds to and potentiates the activation of JAK2 by globally enhancing downstream pathways. In response to leptin, binds simultaneously to both, JAK2 and IRS1 or IRS2, thus mediating formation of a complex of JAK2, SH2B1 and IRS1 or IRS2. Mediates tyrosine phosphorylation of IRS1 and IRS2, resulting in activation of the PI 3-kinase pathway. Acts as positive regulator of NGF-mediated activation of the Akt/Forkhead pathway; prolongs NGF-induced phosphorylation of AKT1 on 'Ser-473' and AKT1 enzymatic activity. Enhances the kinase activity of the cytokine receptor-associated tyrosine kinase JAK2 and of other receptor tyrosine kinases, such as FGFR3 and NTRK1. For JAK2, the mechanism seems to involve dimerization of both, SH2B1 and JAK2. Enhances RET phosphorylation and kinase activity. Isoforms seem to be differentially involved in IGF-I and PDGF-induced mitogenesis (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="5">Self-associates. Homopentamer (By similarity). Forms a heteromultimeric complex with SH2B2 (By similarity). Interacts with SH2B2. Isoform 1 interacts via its SH2 domain with JAK2. Isoform 2 interacts via its SH2 domain and its N-terminus with JAK2; the SH2 domain is required for the major interaction with JAK2 phosphorylated on tyrosine residues; the N-terminus provides a low-affinity binding to JAK2 independent of JAK2 phosphorylation. Isoform 3 interacts via its SH2 domain with JAK2. Isoform 1 interacts via its SH2 domain with INSR; the interaction requires receptor activation. Isoform 3 interacts via its SH2 domain with INSR; the interaction requires receptor activation and requires INSR phosphorylation at 'Tyr-1185'. Isoform 1 interacts with IGF1R; the interaction requires receptor activation. Isoform 2 interacts with PRKAR1A/RET (PTC2) fusion protein; the interaction requires RET 'Tyr-905' and Tyr-981'. Isoform 2 interacts via its SH2 domain with FGFR3; the interaction requires FGFR3 'Tyr-724' and 'Tyr-760'. Isoform 2 interacts with RET; the interaction requires RET kinase activity and RET 'Tyr-981'. Isoform 2 interacts with RAC1. Isoform 2 interacts with PDGFRA and/or PDGFRB; the interaction requires receptor activation. Interacts with ISR1 and ISR2. Isoform 3 is probably part of a complex consisting of INSR, ISR1 and SH2B1. Probably part of a ternary complex consisting of SH2B1, JAK2 and ISR1 or ISR2. May interact with FCER1G (By similarity). Interacts (via SH2 domain) with NTRK1 (phosphorylated) (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310491">
<id>Q9NRF2</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310491">
<id>Q9NRF2</id>
</interactant>
<interactant intactId="EBI-475899">
<id>P06213</id>
<label>INSR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310491">
<id>Q9NRF2</id>
</interactant>
<interactant intactId="EBI-602878">
<id>P42227</id>
<label>Stat3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310491">
<id>Q9NRF2</id>
</interactant>
<interactant intactId="EBI-10764775">
<id>P52631</id>
<label>Stat3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10691662">
<id>Q9NRF2-2</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="24">Membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Nucleus</location>
</subcellularLocation>
<text evidence="5">Shuttles between the nucleus and the cytoplasm.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NRF2-1</id>
<name>1</name>
<name>Alpha</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NRF2-2</id>
<name>2</name>
<name>Beta</name>
<sequence type="described" ref="VSP_032027"/>
</isoform>
<isoform>
<id>Q9NRF2-3</id>
<name>3</name>
<name>Gamma</name>
<sequence type="described" ref="VSP_032028"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13">Widely expressed with highest levels in skeletal muscle and ovary.</text>
</comment>
<comment type="PTM">
<text evidence="10 13 18">Phosphorylated on tyrosine residues in response to receptor kinase stimulation. Phosphorylated by RET.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the SH2B adapter family.</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH10704" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA92537" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB55148" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EMBL" id="AF227967">
<property type="protein sequence ID" value="AAF73912.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF227968">
<property type="protein sequence ID" value="AAF73913.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF227969">
<property type="protein sequence ID" value="AAF73914.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB037720">
<property type="protein sequence ID" value="BAA92537.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK027488">
<property type="protein sequence ID" value="BAB55148.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290332">
<property type="protein sequence ID" value="BAF83021.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049924">
<property type="protein sequence ID" value="CAB43208.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL713760">
<property type="protein sequence ID" value="CAD28530.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC133550">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC010704">
<property type="protein sequence ID" value="AAH10704.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32424.1">
<molecule id="Q9NRF2-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53996.1">
<molecule id="Q9NRF2-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53997.1">
<molecule id="Q9NRF2-3"/>
</dbReference>
<dbReference type="PIR" id="T08662">
<property type="entry name" value="T08662"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139267.1">
<molecule id="Q9NRF2-1"/>
<property type="nucleotide sequence ID" value="NM_001145795.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139268.1">
<molecule id="Q9NRF2-2"/>
<property type="nucleotide sequence ID" value="NM_001145796.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139269.1">
<molecule id="Q9NRF2-3"/>
<property type="nucleotide sequence ID" value="NM_001145797.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139284.1">
<molecule id="Q9NRF2-2"/>
<property type="nucleotide sequence ID" value="NM_001145812.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295222.1">
<molecule id="Q9NRF2-1"/>
<property type="nucleotide sequence ID" value="NM_001308293.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295223.1">
<property type="nucleotide sequence ID" value="NM_001308294.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_056318.2">
<molecule id="Q9NRF2-2"/>
<property type="nucleotide sequence ID" value="NM_015503.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016878603.1">
<property type="nucleotide sequence ID" value="XM_017023114.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016878604.1">
<property type="nucleotide sequence ID" value="XM_017023115.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016878605.1">
<property type="nucleotide sequence ID" value="XM_017023116.1"/>
</dbReference>
<dbReference type="PDB" id="5W3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.39"/>
<property type="chains" value="A=519-628"/>
</dbReference>
<dbReference type="PDBsum" id="5W3R"/>
<dbReference type="SMR" id="Q9NRF2"/>
<dbReference type="BioGRID" id="117455">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="IntAct" id="Q9NRF2">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="MINT" id="Q9NRF2"/>
<dbReference type="STRING" id="9606.ENSP00000321221"/>
<dbReference type="iPTMnet" id="Q9NRF2"/>
<dbReference type="PhosphoSitePlus" id="Q9NRF2"/>
<dbReference type="BioMuta" id="SH2B1"/>
<dbReference type="DMDM" id="313104186"/>
<dbReference type="jPOST" id="Q9NRF2"/>
<dbReference type="MassIVE" id="Q9NRF2"/>
<dbReference type="MaxQB" id="Q9NRF2"/>
<dbReference type="PaxDb" id="Q9NRF2"/>
<dbReference type="PeptideAtlas" id="Q9NRF2"/>
<dbReference type="PRIDE" id="Q9NRF2"/>
<dbReference type="ProteomicsDB" id="82346">
<molecule id="Q9NRF2-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="82347">
<molecule id="Q9NRF2-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="82348">
<molecule id="Q9NRF2-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="26583">
<property type="antibodies" value="279 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000322610">
<molecule id="Q9NRF2-1"/>
<property type="protein sequence ID" value="ENSP00000321221"/>
<property type="gene ID" value="ENSG00000178188"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000337120">
<molecule id="Q9NRF2-2"/>
<property type="protein sequence ID" value="ENSP00000337163"/>
<property type="gene ID" value="ENSG00000178188"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359285">
<molecule id="Q9NRF2-3"/>
<property type="protein sequence ID" value="ENSP00000352232"/>
<property type="gene ID" value="ENSG00000178188"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395532">
<molecule id="Q9NRF2-2"/>
<property type="protein sequence ID" value="ENSP00000378903"/>
<property type="gene ID" value="ENSG00000178188"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000618521">
<molecule id="Q9NRF2-1"/>
<property type="protein sequence ID" value="ENSP00000481709"/>
<property type="gene ID" value="ENSG00000178188"/>
</dbReference>
<dbReference type="GeneID" id="25970"/>
<dbReference type="KEGG" id="hsa:25970"/>
<dbReference type="UCSC" id="uc002dri.4">
<molecule id="Q9NRF2-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="25970"/>
<dbReference type="DisGeNET" id="25970"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000178188.14"/>
<dbReference type="GeneCards" id="SH2B1"/>
<dbReference type="HGNC" id="HGNC:30417">
<property type="gene designation" value="SH2B1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000178188">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="SH2B1"/>
<dbReference type="MIM" id="608937">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NRF2"/>
<dbReference type="OpenTargets" id="ENSG00000178188"/>
<dbReference type="Orphanet" id="261222">
<property type="disease" value="Distal 16p11.2 microdeletion syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="261197">
<property type="disease" value="Proximal 16p11.2 microdeletion syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="329249">
<property type="disease" value="Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA145148084"/>
<dbReference type="eggNOG" id="ENOG502QT43">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000183191"/>
<dbReference type="HOGENOM" id="CLU_014885_4_0_1"/>
<dbReference type="InParanoid" id="Q9NRF2"/>
<dbReference type="KO" id="K12459"/>
<dbReference type="OMA" id="SSTLMPF"/>
<dbReference type="PhylomeDB" id="Q9NRF2"/>
<dbReference type="TreeFam" id="TF323184"/>
<dbReference type="PathwayCommons" id="Q9NRF2"/>
<dbReference type="Reactome" id="R-HSA-1170546">
<molecule id="Q9NRF2-2"/>
<property type="pathway name" value="Prolactin receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2586552">
<molecule id="Q9NRF2-2"/>
<property type="pathway name" value="Signaling by Leptin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-982772">
<molecule id="Q9NRF2-2"/>
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983231">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="SignaLink" id="Q9NRF2"/>
<dbReference type="SIGNOR" id="Q9NRF2"/>
<dbReference type="BioGRID-ORCS" id="25970">
<property type="hits" value="32 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SH2B1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SH2B1"/>
<dbReference type="GenomeRNAi" id="25970"/>
<dbReference type="Pharos" id="Q9NRF2">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9NRF2"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="Q9NRF2">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000178188">
<property type="expression patterns" value="Expressed in right hemisphere of cerebellum and 217 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9NRF2">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9NRF2">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005068">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase adaptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030032">
<property type="term" value="P:lamellipodium assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045840">
<property type="term" value="P:positive regulation of mitotic nuclear division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060391">
<property type="term" value="P:positive regulation of SMAD protein signal transduction"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:2000278">
<property type="term" value="P:regulation of DNA biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd10346">
<property type="entry name" value="SH2_SH2B_family"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR015012">
<property type="entry name" value="Phe_ZIP"/>
</dbReference>
<dbReference type="InterPro" id="IPR036290">
<property type="entry name" value="Phe_ZIP_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR030523">
<property type="entry name" value="SH2B"/>
</dbReference>
<dbReference type="InterPro" id="IPR030521">
<property type="entry name" value="SH2B1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035057">
<property type="entry name" value="SH2B1_SH2"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10872">
<property type="entry name" value="PTHR10872"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10872:SF3">
<property type="entry name" value="PTHR10872:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00169">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08916">
<property type="entry name" value="Phe_ZIP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF109805">
<property type="entry name" value="SSF109805"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<feature type="chain" description="SH2B adapter protein 1" id="PRO_0000323593">
<location>
<begin position="1"/>
<end position="756"/>
</location>
</feature>
<feature type="domain" description="PH">
<location>
<begin position="267"/>
<end position="376"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="8">
<location>
<begin position="527"/>
<end position="625"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with JAK2 (low-affinity binding; independent of JAK2 phosphorylation)" evidence="5">
<location>
<begin position="1"/>
<end position="555"/>
</location>
</feature>
<feature type="region of interest" description="Required for self-association">
<location>
<begin position="24"/>
<end position="85"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RAC1" evidence="5">
<location>
<begin position="85"/>
<end position="196"/>
</location>
</feature>
<feature type="region of interest" description="Required for NGF signaling" evidence="5">
<location>
<begin position="100"/>
<end position="243"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization" evidence="5">
<location>
<begin position="224"/>
<end position="233"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="88"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3">
<location>
<position position="96"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="4">
<location>
<position position="270"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="417"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="420"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK1, JAK2 and PDGFR" evidence="6">
<location>
<position position="439"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK1, JAK2" evidence="6">
<location>
<position position="494"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_032027" evidence="19 20 21 22 23">
<original>EPTTSHDPPQPPEPPSWTDPPQPGAEEASRAPEVAAAAAAAAKERQEKEKAGGGGVPEELVPVVELVPVVELEEAIAPGSEAQGAGSGGDAGVPPMVQLQQSPLGGDGEEGGHPRAINNQYSFV</original>
<variation>GREQAGSHAGVCEGDGCHPDASCTLMPFGASDCVTDHLP</variation>
<location>
<begin position="633"/>
<end position="756"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_032028" evidence="22 23">
<original>EPTTSHDPPQPPEPPSWTDPPQPGAEEASRAPEVAAAAAAAAKERQEKEKAGGGGVPEELVPVVELVPVVELEEAIAPGSEAQGAGSGGDAGVPPMVQLQQSPLGGDGEEGGHPRAINNQYSFV</original>
<variation>GEQSRSAGEEVPVHPRSEAGSRLGAMRGCAREMDATPMPPAPSCPSERVTV</variation>
<location>
<begin position="633"/>
<end position="756"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7498665." id="VAR_039550" evidence="13 16">
<original>T</original>
<variation>A</variation>
<location>
<position position="484"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17850682." id="VAR_039551" evidence="9">
<original>V</original>
<variation>A</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>F</original>
<variation>R</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>A</original>
<variation>D</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>A</original>
<variation>D</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>F</original>
<variation>A</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>A</original>
<variation>D</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>Y</original>
<variation>A</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>F</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>F</original>
<variation>A</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes self-association and interaction with INSR and IGF1R." evidence="13">
<original>R</original>
<variation>A</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF83021." ref="3" evidence="24">
<original>N</original>
<variation>D</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF83021." ref="3" evidence="24">
<original>D</original>
<variation>G</variation>
<location>
<position position="519"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="522"/>
<end position="524"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="528"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="534"/>
<end position="542"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="545"/>
<end position="548"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="551"/>
<end position="556"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="558"/>
<end position="560"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="564"/>
<end position="570"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="573"/>
<end position="581"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="587"/>
<end position="589"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="592"/>
<end position="596"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="597"/>
<end position="606"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="614"/>
<end position="616"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5W3R"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62985"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q91ZM2"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10718198"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751854"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11827956"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14565960"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15767667"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16569669"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17471236"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9694882"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9742218"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10718198"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15767667"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="756" mass="79366" checksum="CF680B57114CB1D3" modified="2010-11-30" version="3">MNGAPSPEDGASPSSPPLPPPPPPSWREFCESHARAAALDFARRFRLYLASHPQYAGPGAEAAFSRRFAELFLQHFEAEVARASGSLSPPILAPLSPGAEISPHDLSLESCRVGGPLAVLGPSRSSEDLAGPLPSSVSSSSTTSSKPKLKKRFSLRSVGRSVRGSVRGILQWRGTVDPPSSAGPLETSSGPPVLGGNSNSNSSGGAGTVGRGLVSDGTSPGERWTHRFERLRLSRGGGALKDGAGMVQREELLSFMGAEEAAPDPAGVGRGGGVAGPPSGGGGQPQWQKCRLLLRSEGEGGGGSRLEFFVPPKASRPRLSIPCSSITDVRTTTALEMPDRENTFVVKVEGPSEYIMETVDAQHVKAWVSDIQECLSPGPCPATSPRPMTLPLAPGTSFLTRENTDSLELSCLNHSESLPSQDLLLGPSESNDRLSQGAYGGLSDRPSASISPSSASIAASHFDSMELLPPELPPRIPIEEGPPTGTVHPLSAPYPPLDTPETATGSFLFQGEPEGGEGDQPLSGYPWFHGMLSRLKAAQLVLTGGTGSHGVFLVRQSETRRGEYVLTFNFQGKAKHLRLSLNEEGQCRVQHLWFQSIFDMLEHFRVHPIPLESGGSSDVVLVSYVPSSQRQQEPTTSHDPPQPPEPPSWTDPPQPGAEEASRAPEVAAAAAAAAKERQEKEKAGGGGVPEELVPVVELVPVVELEEAIAPGSEAQGAGSGGDAGVPPMVQLQQSPLGGDGEEGGHPRAINNQYSFV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

